Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.

NCT07416240 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

BIOLOGICAL: Claudin18.2 Targeted Activated Dendritic Cells
BIOLOGICAL: Claudin18.2 Targeted CAR-T Cells

Sponsor

Hainan Cancer Hospital

Collaborators

[object Object]